Warning
This is an unofficial archive of PsychonautWiki as of 2025-08-08T03:33:20Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.

Template:SubstanceBox/N-Methyl-Cyclazodone: Difference between revisions

From PsychonautWiki Archive
Jump to navigation Jump to search
← Older edit
>Carphknight
m Edit 1
>Carphknight
m Red color
 
(45 intermediate revisions by 2 users not shown)
Line 35: Line 35:
     <!-- Structure -->
     <!-- Structure -->
     |MolecularStructureCaption=
     |MolecularStructureCaption=
     |SkeletalImageFile=File:DMT.svg
     |SkeletalImageFile=File:N-methylcyclazodone.svg
     |SkeletalImageWidth=245px
     |SkeletalImageWidth=245px
     |3DImageFile=
     |3DImageFile=
Line 41: Line 41:


     <!-- Nomenclature -->
     <!-- Nomenclature -->
     |NameCommon=DMT, Dimethyltryptamine, Dmitri
     |NameCommon=N-Methyl-Cyclazodone, N-Cyclopropyl-N-Methylpemoline, NMC
     |NameSubstitution=N,N-Dimethyltryptamine
     |NameSubstitution=N-Methyl-Cyclazodone
     |NameSystematic=2-(1H-Indol-3-yl)-N,N-dimethylethanamine <!-- Use IUPAC naming convention -->
     |NameSystematic=2-(Cyclopropyl(methyl)amino)-5-phenyl-1,3-oxazol-4-one <!-- Use IUPAC naming convention -->


     <!-- Class Membership -->
     <!-- Class Membership -->
     |EffectClass=[[psychoactive class::Psychedelic]]
     |EffectClass=[[psychoactive class::Stimulant]]
     |ChemicalClass=[[chemical class::Tryptamine]]
     |ChemicalClass=[[chemical class::Substituted aminorexes]]
   
 


     <!-- Dosage/Duration per ROA -->
     <!-- Dosage/Duration per ROA -->
Line 54: Line 56:
     |OralROA_Collapsed=false
     |OralROA_Collapsed=false
     |OralROA_Caption=
     |OralROA_Caption=
     |OralROA_Bioavailability=[[Oral min bioavailability::x]]% - [[Oral max bioavailability::y]]%
     |OralROA_Bioavailability=
     |OralROA_Microdose=
     |OralROA_Microdose=
     |OralROA_Threshold=[[Oral threshold dose::x]] -  [[Oral dose units::mg]]  
     |OralROA_Threshold=[[Oral threshold dose::5]] -  [[Oral dose units::mg]]  
     |OralROA_Light=[[Oral min light dose::x]] - [[Oral max light dose::y]] mg
     |OralROA_Light=[[Oral min light dose::5]] - [[Oral max light dose::10]] mg
     |OralROA_Common=[[Oral min common dose::x]] - [[Oral max common dose::y]] mg
     |OralROA_Common=[[Oral min common dose::10]] - [[Oral max common dose::20]] mg
     |OralROA_Strong=[[Oral min strong dose::x]] - [[Oral max strong dose::y]] mg
     |OralROA_Strong=[[Oral min strong dose::20]] - [[Oral max strong dose::30]] mg
     |OralROA_Heavy=[[Oral heavy dose::x]] mg +
     |OralROA_Heavy=[[Oral heavy dose::30]] mg + <span style="color:red">'''Liver damage may result from heavy or sustained usage.'''</span>
     |OralROA_TimelineFile=
     |OralROA_TimelineFile=
     |OralROA_TimelineWidth=
     |OralROA_TimelineWidth=
     |OralROA_Duration=[[Oral min total time::x]] - [[Oral max total time::y]] [[Oral total time units::hours]]
     |OralROA_Duration=[[Oral min total time::9]] - [[Oral max total time::12]] [[Oral total time units::hours]]
     |OralROA_Onset=[[Oral min onset time::x]] - [[Oral max onset time::y]] [[Oral onset time units::minutes]]
     |OralROA_Onset=[[Oral min onset time::20]] - [[Oral max onset time::35]] [[Oral onset time units::minutes]]
     |OralROA_Comeup=[[Oral min comeup time::x]] - [[Oral max comeup time::y]] [[Oral comeup time units::minutes]]
     |OralROA_Comeup=[[Oral min comeup time::15]] - [[Oral max comeup time::25]] [[Oral comeup time units::minutes]]
     |OralROA_Peak=[[Oral min peak time::x]] - [[Oral max peak time::y]] [[Oral peak time units::hours]]
     |OralROA_Peak=[[Oral min peak time::5]] - [[Oral max peak time::7]] [[Oral peak time units::hours]]
     |OralROA_Offset=[[Oral min offset time::x]] - [[Oral max offset time::y]] [[Oral offset time units::hours]]
     |OralROA_Offset=[[Oral min offset time::3]] - [[Oral max offset time::4]] [[Oral offset time units::hours]]
     |OralROA_Aftereffects=[[Oral min afterglow time::x]] - [[Oral max afterglow time::y]] [[Oral afterglow time units::hours]]
     |OralROA_Aftereffects=


     |SublingualROA=true
     |SublingualROA=false
     |SublingualROA_Collapsed=true
     |SublingualROA_Collapsed=true
     |SublingualROA_Caption=
     |SublingualROA_Caption=
Line 92: Line 94:
     |BuccalROA_Collapsed=True
     |BuccalROA_Collapsed=True
     |BuccalROA_Caption=
     |BuccalROA_Caption=
     |BuccalROA_Bioavailability=[[Buccal min bioavailability::x]]% - [[Buccal max bioavailability::y]]%<ref>APA formatted citation</ref>
     |BuccalROA_Bioavailability=[[Buccal min bioavailability::x]]% - [[Buccal max bioavailability::y]]%
     |BuccalROA_Microdose=
     |BuccalROA_Microdose=
     |BuccalROA_Threshold=[[Buccal threshold dose::x]] -  [[Buccal dose units::mg]]  
     |BuccalROA_Threshold=[[Buccal threshold dose::x]] -  [[Buccal dose units::mg]]  
Line 111: Line 113:
     |InsufflatedROA_Collapsed=True
     |InsufflatedROA_Collapsed=True
     |InsufflatedROA_Caption=
     |InsufflatedROA_Caption=
     |InsufflatedROA_Bioavailability=[[Insufflated min bioavailability::x]]% - [[Insufflated max bioavailability::y]]%<ref>APA formatted citation</ref>
     |InsufflatedROA_Bioavailability=[[Insufflated min bioavailability::x]]% - [[Insufflated max bioavailability::y]]%
     |InsufflatedROA_Microdose=
     |InsufflatedROA_Microdose=
     |InsufflatedROA_Threshold=[[Insufflated threshold dose::x]] -  [[Insufflated dose units::mg]]  
     |InsufflatedROA_Threshold=[[Insufflated threshold dose::x]] -  [[Insufflated dose units::mg]]  
Line 149: Line 151:
     |TransdermalROA_Collapsed=True
     |TransdermalROA_Collapsed=True
     |TransdermalROA_Caption=
     |TransdermalROA_Caption=
     |TransdermalROA_Bioavailability=[[Transdermal min bioavailability::x]]% - [[Transdermal max bioavailability::y]]%<ref>APA formatted citation</ref>
     |TransdermalROA_Bioavailability=[[Transdermal min bioavailability::x]]% - [[Transdermal max bioavailability::y]]%
     |TransdermalROA_Microdose=
     |TransdermalROA_Microdose=
     |TransdermalROA_Threshold=[[Transdermal threshold dose::x]] -  [[Transdermal dose units::mg]]  
     |TransdermalROA_Threshold=[[Transdermal threshold dose::x]] -  [[Transdermal dose units::mg]]  
Line 168: Line 170:
     |SubcutaneousROA_Collapsed=True
     |SubcutaneousROA_Collapsed=True
     |SubcutaneousROA_Caption=
     |SubcutaneousROA_Caption=
     |SubcutaneousROA_Bioavailability=[[Subcutaneous min bioavailability::x]]% - [[Subcutaneous max bioavailability::y]]%<ref>APA formatted citation</ref>
     |SubcutaneousROA_Bioavailability=[[Subcutaneous min bioavailability::x]]% - [[Subcutaneous max bioavailability::y]]%
     |SubcutaneousROA_Microdose=
     |SubcutaneousROA_Microdose=
     |SubcutaneousROA_Threshold=[[Subcutaneous threshold dose::x]] -  [[Subcutaneous dose units::mg]]  
     |SubcutaneousROA_Threshold=[[Subcutaneous threshold dose::x]] -  [[Subcutaneous dose units::mg]]  
Line 187: Line 189:
     |IntramuscularROA_Collapsed=true
     |IntramuscularROA_Collapsed=true
     |IntramuscularROA_Caption=
     |IntramuscularROA_Caption=
     |IntramuscularROA_Bioavailability=[[Intramuscular min bioavailability::x]]% - [[Intramuscular max bioavailability::y]]%<ref>APA formatted citation</ref>
     |IntramuscularROA_Bioavailability=[[Intramuscular min bioavailability::x]]% - [[Intramuscular max bioavailability::y]]%
     |IntramuscularROA_Microdose=
     |IntramuscularROA_Microdose=
     |IntramuscularROA_Threshold=[[Intramuscular threshold dose::x]] -  [[Intramuscular dose units::mg]]  
     |IntramuscularROA_Threshold=[[Intramuscular threshold dose::x]] -  [[Intramuscular dose units::mg]]  
Line 206: Line 208:
     |IntravenousROA_Collapsed=true
     |IntravenousROA_Collapsed=true
     |IntravenousROA_Caption=
     |IntravenousROA_Caption=
     |IntravenousROA_Bioavailability=[[Intravenous min bioavailability::x]]% - [[Intravenous max bioavailability::y]]%<ref>APA formatted citation</ref>
     |IntravenousROA_Bioavailability=[[Intravenous min bioavailability::x]]% - [[Intravenous max bioavailability::y]]%
     |IntravenousROA_Microdose=
     |IntravenousROA_Microdose=
     |IntravenousROA_Threshold=[[Intravenous threshold dose::x]] -  [[Intravenous dose units::mg]]  
     |IntravenousROA_Threshold=[[Intravenous threshold dose::x]] -  [[Intravenous dose units::mg]]  

Latest revision as of 16:58, 27 December 2021

SubstanceBox/N-Methyl-Cyclazodone
Chemical Nomenclature
Common names N-Methyl-Cyclazodone, N-Cyclopropyl-N-Methylpemoline, NMC
Substitutive name N-Methyl-Cyclazodone
Systematic name 2-(Cyclopropyl(methyl)amino)-5-phenyl-1,3-oxazol-4-one
Class Membership
Psychoactive class Stimulant
Chemical class Substituted aminorexes
Routes of Administration

WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. See responsible use section.



⇣ Oral
Dosage
Threshold 5 - mg
Light 5 - 10 mg
Common 10 - 20 mg
Strong 20 - 30 mg
Heavy 30 mg + Liver damage may result from heavy or sustained usage.
Duration
Total 9 - 12 hours
Onset 20 - 35 minutes
Come up 15 - 25 minutes
Peak 5 - 7 hours
Offset 3 - 4 hours









DISCLAIMER: PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy.


Retrieved from "https://psy.st/index.php?title=Template:SubstanceBox/N-Methyl-Cyclazodone&oldid=464335"